E34.50

Androgen insensitivity syndrome, unspecified

Billable FY2026 2025-10-01 → 2026-09-30

This is the unspecified option. 2 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.

Exclusions 4 never code together

E34code

Excludes1

Excludes1

Excludes1

transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 2

Inclusion terms

Notes

All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8 E07.0 E16-E31 E34.-

Index entries leading here 5

Insensitivity
- androgen E34.50
Syndrome — see also Disease
- androgen insensitivity E34.50
- androgen resistance E34.50
Androgen insensitivity syndrome E34.50
Androgen resistance syndrome E34.50
Disorder (of) — see also Disease
- receptor, hormonal, peripheral E34.50

Alongside this code 2 same parent — E34.5

Additional references

AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

Present FY2024–FY2027.